Agios Pharmaceuticals (AGIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 0 | 94,387 | 43,011 | 69,892 | 59,119 |
| Cost of Goods | N/A | 1,397 | N/A | N/A | N/A |
| Gross Profit | N/A | 92,990 | 43,011 | 69,892 | 59,119 |
| Operating Expenses | 316,269 | 455,866 | 363,805 | 270,877 | 177,819 |
| Operating Income | -316,269 | -362,479 | -320,794 | -200,985 | -118,700 |
| Other Income | 14,861 | 16,451 | 6,124 | 2,514 | 968 |
| Pre-tax Income | -301,408 | -346,028 | -314,670 | -198,471 | -117,732 |
| Net Income Continuous | -301,408 | -346,028 | -314,670 | -198,471 | -117,732 |
| Net Income Discontinuous | -110,064 | N/A | N/A | N/A | N/A |
| Net Income | $-411,472 | $-346,028 | $-314,670 | $-198,471 | $-117,732 |
| EPS Basic Total Ops | -6.86 | -6.03 | -6.75 | -5.07 | -3.15 |
| EPS Basic Continuous Ops | -5.02 | -6.03 | -6.75 | -5.07 | -3.15 |
| EPS Basic Discontinuous Ops | -1.84 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | -6.86 | -6.03 | -6.75 | -5.07 | -3.15 |
| EPS Diluted Continuous Ops | -5.02 | -6.03 | -6.75 | -5.07 | -3.15 |
| EPS Diluted Discontinuous Ops | -1.84 | N/A | N/A | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -6.86 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-311,376 | $-359,144 | $-314,373 | $-194,504 | $-114,819 |